Keros Therapeutics Earnings
NASDAQ: KROSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
11.95+0.31 (+2.66%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Wed, Nov 4, 2026
Fiscal period
Sep/2026
EPS estimate
$-0.96
Keros Therapeutics earnings summary
Keros Therapeutics is scheduled to report Sep/2026 earnings on Nov 4, 2026, with analysts expecting EPS of $-0.96.
Summary generated from market data by MetaCap's automated system. Methodology